Key result
Administration of losartan and spironolactone enabled withdrawal from furosemide and KCl and improved total body potassium levels in a patient with pseudo-Bartter's syndrome.
Why the study?
Does blocking the renin-angiotensin-aldosterone system with losartan and spironolactone enable withdrawal from furosemide and KCl in a patient with pseudo-Bartter's syndrome?
Case Report (n=1)
Does blocking the renin-angiotensin-aldosterone system with losartan and spironolactone enable withdrawal from furosemide and KCl in a patient with pseudo-Bartter's syndrome?
Blocking the renin-angiotensin-aldosterone system with an ARB and spironolactone may be an effective treatment for pseudo-Bartter's syndrome to correct hypokalemia and stop diuretic abuse.
Answers are grounded in this paper and cite their sources.
May support RAAS blockade to correct hypokalemia in pseudo-Bartter's syndrome; hypothesis-generating case report requiring prospective validation.
A 30-year-old woman with pseudo-Bartter's syndrome was referred to our department because of hypokalemic symptoms caused by outrageous abuse of furosemide and by KCl infusion administered to compensate for it. As an attempt to break this vicious cycle, we first tried to change furosemide with azosemide, a long-lasting loop diuretics, to avoid acute excessive diuresis and excretion of potassium. Administration of losartan effectively attenuated the concentration of extremely activated plasma aldosterone. Administration of spironolactone reduced aldosterone breakthrough induced by losartan and the patient was released from both furosemide and KCl. Blocking renin-angiotensin-aldosterone system demonstrated to be an effective treatment for pseudo-Bartter's syndrome by the improvement of the total body potassium level which was decreased before treatment.
No takes yet. Share an insight, caveat, or question.
Ashizawa et al. (2004) conducted a case report in pseudo-Bartter's syndrome (n=1). Losartan and spironolactone was evaluated on Withdrawal from furosemide and KCl and improvement of total body potassium level. Administration of losartan and spironolactone enabled withdrawal from furosemide and KCl and improved total body potassium levels in a patient with pseudo-Bartter's syndrome.
Synapse has enriched 10 related papers. Consider them for comparative context: